227 related articles for article (PubMed ID: 16700872)
1. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond.
Stepp DW
Clin Exp Pharmacol Physiol; 2006; 33(5-6):407-14. PubMed ID: 16700872
[TBL] [Abstract][Full Text] [Related]
2. [Insulin, nitric oxide and the sympathetic nervous system: from crossroads to metabolic and cardiovascular homeostasis].
Sartori C; Thalmann S; Jayet PY; Duplain H; Vollenweider P; Scherrer U
Rev Med Suisse Romande; 2004 Oct; 124(10):635-8. PubMed ID: 15573509
[TBL] [Abstract][Full Text] [Related]
3. [Defective nitric oxide homeostasis. Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality].
Schwab M; Bloch J; Duplain H; Sartori C; Scherrer U
Medicina (B Aires); 2008; 68(3):243-50. PubMed ID: 18689158
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
[TBL] [Abstract][Full Text] [Related]
5. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
Newsholme P; Homem De Bittencourt PI; O' Hagan C; De Vito G; Murphy C; Krause MS
Clin Sci (Lond); 2009 Nov; 118(5):341-9. PubMed ID: 19922417
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, hyperinsulinemia and hypertension.
Weidmann P; de Courten M; Böhlen L
J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of a novel silicate inositol complex of the nitric oxide precursor arginine in the obese insulin-resistant JCR:LA-cp rat.
Proctor SD; Kelly SE; Vine DF; Russell JC
Metabolism; 2007 Oct; 56(10):1318-25. PubMed ID: 17884439
[TBL] [Abstract][Full Text] [Related]
9. Insulin and the vasculature--old actors, new roles.
Baron AD
J Investig Med; 1996 Oct; 44(8):406-12. PubMed ID: 8952221
[TBL] [Abstract][Full Text] [Related]
10. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
11. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
[TBL] [Abstract][Full Text] [Related]
12. Obesity and endothelial dysfunction.
Shankar SS; Steinberg HO
Semin Vasc Med; 2005 Feb; 5(1):56-64. PubMed ID: 15968581
[TBL] [Abstract][Full Text] [Related]
13. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
15. Vascular function in the metabolic syndrome and the effects on skeletal muscle perfusion: lessons from the obese Zucker rat.
Frisbee JC; Delp MD
Essays Biochem; 2006; 42():145-61. PubMed ID: 17144886
[TBL] [Abstract][Full Text] [Related]
16. Role of aldosterone and angiotensin II in insulin resistance: an update.
Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
[TBL] [Abstract][Full Text] [Related]
17. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
Kearney MT; Duncan ER; Kahn M; Wheatcroft SB
Exp Physiol; 2008 Jan; 93(1):158-63. PubMed ID: 17933859
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension.
Raij L
Semin Nephrol; 1999 May; 19(3):296-303. PubMed ID: 10226336
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
